Insider Transactions in Q1 2019 at Tcr2 Therapeutics Inc. (TCRR)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2019
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
706,666
+14.85%
|
$10,599,990
$15.0 P/Share
|
|
Feb 19
2019
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,148,297
+28.57%
|
-
|
|
Feb 19
2019
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,667
+16.51%
|
$10,000,005
$15.0 P/Share
|
|
Feb 19
2019
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,704,315
+29.73%
|
-
|
|
Feb 19
2019
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
807,256
+50.0%
|
-
|